ESLA Institutional Ownership
Top institutional (13F) holders of ESLA and 5%+ (13D/G) positions, sourced from SEC EDGAR.
Institutional owners
12
Institutional value
$979.7K
Top holder
Vanguard Capital Management
Couldn’t find the data you were looking for?
We haven’t added Estrella Immunopharma, Inc.’s filings yet. We add companies and filings all the time.
Track ESLA and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Top holders
| Holder | Filed | Value |
|---|---|---|
| Vanguard Capital Managementinvestment advisor | Aug 13, 2026 | $433.5K |
| WELLS FARGO & COMPANY/MNinvestment advisor | Jul 8, 2026 | $280.3K |
| GEODE CAPITAL MANAGEMENT, LLCinvestment advisor | Nov 6, 2026 | $65.9K |
| BlackRock, Inc.holding company | Aug 7, 2026 | $54.1K |
| STATE STREET CORPORATIONholding company | Sep 22, 2026 | $45K |
| RENAISSANCE TECHNOLOGIES LLCinvestment advisor | Aug 13, 2026 | $40.7K |
| NORTHERN TRUST CORPinvestment advisor | Aug 13, 2026 | $36.3K |
| D. E. Shaw & Co., Inc.investment advisor | Aug 14, 2026 | $12.5K |
| ROYAL BANK OF CANADAholding company | May 15, 2026 | $7K |
| CITIGROUP INCinvestment advisor | Nov 4, 2026 | $2K |
| UBS Group AGbank | Aug 13, 2026 | $1.8K |
| MORGAN STANLEYholding company | May 15, 2026 | $1 |
5%+ holders
Current stakes of 5% or more from Schedule 13D and 13G filings. A joint filing shows once, under its lead filer.
No current 5%+ holders of ESLA on file.
Never miss a ESLA filing.
Get an email when ESLA files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR Schedule 13D / 13G and 13F filings.